Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    36

Stocks News & Analysis

stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks

The 10 best US dividend stocks

These undervalued stocks with reliable dividends are worth considering.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,543.7034.10-0.40%
CAC 407,431.0459.24-0.79%
DAX 4020,214.79102.31-0.50%
Dow JONES (US)41,938.45696.75-1.63%
FTSE 1008,248.4971.20-0.86%
HKSE19,064.29176.60-0.92%
NASDAQ19,161.63317.25-1.63%
Nikkei 22539,190.40414.69-1.05%
NZX 50 Index12,895.9847.76-0.37%
S&P 5005,827.0491.21-1.54%
S&P/ASX 2008,294.1035.10-0.42%
SSE Composite Index3,168.5242.87-1.33%

Market Movers